PACTR201702001970148
Other
未知
Assessing the impact of clinic days dedicated to providing HIV services for post-partum HIV-positive mothers and their HIV-exposed infants (¿Umoyo¿) on 12 month retention of infants
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Clinton Health Access Initiative
- Enrollment
- 448
- Status
- Other
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The following will be used as inclusion criteria for the program:
- •¿For the retrospective study, HIV exposed infants (HEI)s will be included if they are 1\) over the age of 6 weeks and under 3 months of age at 12 \- 9 months before the launch of the MIP clinic program and 2\) receiving services from a study facility.
- •¿For the prospective study, HEIs will be included if they are 1\) over the age of 6 weeks and under 3 months of age at the time of the launch of the MIP clinic and 2\) receiving services from a study facility.
- •¿For mother¿s questionnaire, women will be eligible for inclusion if they 1\) are age 18 years or older, 2\) are HIV\-positive and 3\) are receiving under\-five services for their infant from a study site. At baseline, any woman meeting the other criteria and attending the under\-five clinic will be eligible. At end line, women who have attended at least three Umoyo clinic days will be eligible.
Exclusion Criteria
- •The following will be used as exclusion criteria for the program:
- •¿For the retrospective study, any HEI who is under age 6 weeks or over 3 months of age at 12 \-9 months before the launch of the MIP program will be excluded.
- •¿For the prospective study, any HEI who is under age 6 weeks or over 12 months of age at the time of the Umoyo clinic launch will be excluded. HEIs will also be excluded if they have already tested positive before age 12 months.
- •¿For mother¿s exit questionnaire, women will be excluded if they 1\) are under 18 years, 2\) are not HIV\-positive or 3\) do not regularly receive under\-five services for their infant from a study site. At end line, women will be excluded if they have not attended at least three Umoyo clinic days.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A trial comparing effect of two different regimes of iron supplementation on markers of oxidative stress and anti-oxidant status in children with iron deficiency anemiaHealth Condition 1: null- Iron deficiency anemiaCTRI/2010/091/001102il72
Completed
Not Applicable
Study of the clinical efficacy and number of days of administration of cefditoren pivoxil in the treatment of adult acute uncomplicated cystitisAdult acute uncomplicated cystitisJPRN-UMIN000010449Okayama Urological Research Group120
Completed
Not Applicable
Study of the clinical efficacy and number of days of tebipenem pivoxil administration for the treatment of pediatric bacterial pneumonia.Pediatric bacterial pneumoniaJPRN-UMIN000010144Department of Pediatrics, Kawasaki Medical School100
Recruiting
Not Applicable
Comparison of the effect of two methods of prescribing exercise on neck paiIRCT20181219042055N2Iran University of Medical Sciences44
Active, not recruiting
Phase 1
A pilot study on the effects of an alternate-day corticosteroid regimen in children with active crohn’s disease - Alternate-day corticosteroid regimen in children with Crohn’s diseaseCrohn's diseaseMedDRA version: 12. Level: LLT Classification code 10013099 Term: Disease CrohnsEUCTR2010-022017-26-GBCentral Manchester University Hospitals Foundation Trust27